COX-2 and VEGF in Non-Small Cell Lung Cancer
Author Information
Author(s): Luo Honghe, Chen Zhenguang, Jin Hui, Zhuang Mei, Wang Tao, Su Chunhua, Lei Yiyan, Zou Jianyong, Zhong Beilong
Primary Institution: The First Affiliated Hospital, Sun Yat-sen University
Hypothesis
The study aims to investigate the signaling pathway that links COX-2 with VEGF up-regulation in non-small cell lung cancer (NSCLC).
Conclusion
COX-2 may contribute to VEGF expression in NSCLC, potentially involving the PKC pathway.
Supporting Evidence
- COX-2 over-expression correlated with microvessel density and VEGF expression in NSCLC samples.
- Exogenously applied COX-2 stimulated the growth of NSCLC cells.
- Inhibitors of PKC and PGE2 attenuated COX-2-induced VEGF expression in NSCLC cells.
Takeaway
This study found that a protein called COX-2 helps cancer cells make a substance called VEGF, which helps tumors grow by creating new blood vessels.
Methodology
The study used immunohistochemistry to detect COX-2 expression in NSCLC samples and assessed its association with VEGF and microvessel density.
Participant Demographics
63 male and 21 female patients with a mean age of 58 years.
Statistical Information
P-Value
P = 0.001
Confidence Interval
95% CI: 3.387 - 28.564
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website